139 related articles for article (PubMed ID: 19959081)
21. Upregulation of the TGFbeta signalling pathway by Bcr-Abl: implications for haemopoietic cell growth and chronic myeloid leukaemia.
Møller GM; Frost V; Melo JV; Chantry A
FEBS Lett; 2007 Apr; 581(7):1329-34. PubMed ID: 17349636
[TBL] [Abstract][Full Text] [Related]
22. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].
González FA; Villegas A; Ferro MT; San Román C; Sáez I; López M; del Potro E; Alvarez A; Martínez R; Díaz Madiavilla J
Med Clin (Barc); 1993 Oct; 101(14):521-4. PubMed ID: 8231395
[TBL] [Abstract][Full Text] [Related]
23. Effects of age on prognosis with imatinib mesylate therapy for patients with Philadelphia chromosome-positive chronic myelogenous leukemia.
Cortes J; Talpaz M; O'Brien S; Giles F; Beth Rios M; Shan J; Faderl S; Garcia-Manero G; Ferrajoli A; Wierda W; Kantarjian H
Cancer; 2003 Sep; 98(6):1105-13. PubMed ID: 12973833
[TBL] [Abstract][Full Text] [Related]
24. [Incidence of chronic myeloid leukemia in 6 regions of Russia according to the data of the 2009-2012 population-based study].
Kulikov SM; Vinogradova OIu; Chelysheva EIu; Tishchenko IA; Galaĭko MA; Lazareva OV; Senderova OM; Pepeliaeva VM; Meresiĭ SV; Luchinin AS; Ovsepian VA; Miliutina GI; Gavrilova LV; Avdeeva LB; Neverova AL; Turkina AG
Ter Arkh; 2014; 86(7):24-30. PubMed ID: 25314774
[TBL] [Abstract][Full Text] [Related]
25. Using healthcare claims data to analyze the prevalence of BCR-ABL-positive chronic myeloid leukemia in France: A nationwide population-based study.
Foulon S; Cony-Makhoul P; Guerci-Bresler A; Delord M; Solary E; Monnereau A; Bonastre J; Tubert-Bitter P
Cancer Med; 2019 Jun; 8(6):3296-3304. PubMed ID: 31038849
[TBL] [Abstract][Full Text] [Related]
26. [Descriptive epidemiology of myeloid leukemia].
Matsuo K; Ito H
Nihon Rinsho; 2009 Oct; 67(10):1847-51. PubMed ID: 19860178
[TBL] [Abstract][Full Text] [Related]
27. Evolution of clinical trial endpoints in chronic myeloid leukemia: efficacious therapies require sensitive monitoring techniques.
Tibes R; Mesa RA
Leuk Res; 2012 Jun; 36(6):664-71. PubMed ID: 22459332
[TBL] [Abstract][Full Text] [Related]
28. Treating chronic myeloid leukaemia: NICE guidance.
Dowling M; Meenaghan T; Kelly M
Br J Nurs; 2012 Feb 23-Mar 7; 21(4):S16-7. PubMed ID: 22470902
[TBL] [Abstract][Full Text] [Related]
29. Incidence of chronic myeloid leukemia and patient survival: results of five French population-based cancer registries 1980-2009.
Penot A; Preux PM; Le Guyader S; Collignon A; Herry A; Dufour V; Monnereau A; Woronoff AS; Troussard X; Pons E; Bordessoule D; Maynadié M
Leuk Lymphoma; 2015 Jun; 56(6):1771-7. PubMed ID: 25535815
[TBL] [Abstract][Full Text] [Related]
30. Population-based assessment of chronic myeloid leukemia in Sweden: striking increase in survival and prevalence.
Gunnarsson N; Sandin F; Höglund M; Stenke L; Björkholm M; Lambe M; Olsson-Strömberg U; Richter J; Själander A
Eur J Haematol; 2016 Oct; 97(4):387-92. PubMed ID: 26833713
[TBL] [Abstract][Full Text] [Related]
31. The chronic myeloid leukaemia story in the United Kingdom since 1960.
Clark RE
Br J Haematol; 2020 Nov; 191(4):521-526. PubMed ID: 33190253
[TBL] [Abstract][Full Text] [Related]
32. Current management of CML patients: Summary of the Italian Consensus Meeting held in Rome, April 11-12, 2013.
Breccia M; Alimena G; Baccarani M; Bocchia M; Di Raimondo F; Gambacorti-Passerini C; Gozzini A; Morra E; Pane F; Pregno P; Rege-Cambrin G; Rosti G; Specchia G; Vigneri P; Saglio G
Crit Rev Oncol Hematol; 2014 Jun; 90(3):181-9. PubMed ID: 24405858
[TBL] [Abstract][Full Text] [Related]
33. The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries.
Hoffmann VS; Baccarani M; Hasford J; Lindoerfer D; Burgstaller S; Sertic D; Costeas P; Mayer J; Indrak K; Everaus H; Koskenvesa P; Guilhot J; Schubert-Fritschle G; Castagnetti F; Di Raimondo F; Lejniece S; Griskevicius L; Thielen N; Sacha T; Hellmann A; Turkina AG; Zaritskey A; Bogdanovic A; Sninska Z; Zupan I; Steegmann JL; Simonsson B; Clark RE; Covelli A; Guidi G; Hehlmann R
Leukemia; 2015 Jun; 29(6):1336-43. PubMed ID: 25783795
[TBL] [Abstract][Full Text] [Related]
34. Differences in treatment and monitoring of chronic myeloid leukemia with regard to age, but not sex: Results from a population-based study.
Lauseker M; Gerlach R; Worseg W; Haferlach T; Tauscher M; Hasford J; Hoffmann VS
Eur J Haematol; 2019 Oct; 103(4):362-369. PubMed ID: 31309640
[TBL] [Abstract][Full Text] [Related]
35. Estimation of CML incidence: disagreement between national cancer registry and health claims data system in Taiwan.
Chang CS; Lee K; Yang YH; Lin MT; Hsu CN
Leuk Res; 2011 May; 35(5):e53-4. PubMed ID: 21255835
[No Abstract] [Full Text] [Related]
36. Adherence to quality indicators in chronic myeloid leukemia care: results from a population-based study in The Netherlands.
Ector GICG; Geelen IGP; Dinmohamed AG; Hoogendoorn M; Westerweel PE; Hermens RPMG; Blijlevens NMA
Leuk Lymphoma; 2023 Feb; 64(2):424-432. PubMed ID: 36369821
[TBL] [Abstract][Full Text] [Related]
37. Increased prevalence of prior malignancies and autoimmune diseases in patients diagnosed with chronic myeloid leukemia.
Gunnarsson N; Höglund M; Stenke L; Wållberg-Jonsson S; Sandin F; Björkholm M; Dreimane A; Lambe M; Markevärn B; Olsson-Strömberg U; Wadenvik H; Richter J; Själander A
Leukemia; 2016 Jul; 30(7):1562-7. PubMed ID: 27080811
[TBL] [Abstract][Full Text] [Related]
38. Myeloproliferative disease in children: a demographic study.
Reid MM; Saunders PW; Kernahan J
J Clin Pathol; 1988 Aug; 41(8):883-5. PubMed ID: 3170776
[TBL] [Abstract][Full Text] [Related]
39. Improved survival boosts the prevalence of chronic myeloid leukemia: predictions from a population-based study.
Lauseker M; Gerlach R; Tauscher M; Hasford J
J Cancer Res Clin Oncol; 2016 Jul; 142(7):1441-7. PubMed ID: 27085527
[TBL] [Abstract][Full Text] [Related]
40. The role of clinical pharmacists in treatment adherence: fast impact in suppression of chronic myeloid leukemia development and symptoms.
Moulin SM; Eutrópio FJ; Souza JO; Busato FO; Olivieri DN; Tadokoro CE
Support Care Cancer; 2017 Mar; 25(3):951-955. PubMed ID: 27866336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
